Current Neurology and Neuroscience Reports

, Volume 6, Issue 5, pp 355–357

The pleomorphic pathology of inherited parkinson’s disease: Lessons from LRRK2

Invited Commentary

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Moore DJ, West AB, Dawson VL, Dawson TM: Molecular pathophysiology of Parkinson’s disease. Annu Rev Neurosci 2005, 28:57–87.PubMedCrossRefGoogle Scholar
  2. 2.
    Zimprich A, Biskup S, Leitner P, et al.: Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology. Neuron 2004, 44:601–607.PubMedCrossRefGoogle Scholar
  3. 3.
    Paisan-Ruiz C, Jain S, Evans EW, et al.: Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease. Neuron 2004, 44:595–600.PubMedCrossRefGoogle Scholar
  4. 4.
    Bosgraaf L, Van Haastert PJ: Roc, a Ras/GTPase domain in complex proteins. Biochim Biophys Acta 2003, 1643:5–10.PubMedCrossRefGoogle Scholar
  5. 5.
    Mata IF, Kachergus JM, Taylor JP, et al.: Lrrk2 pathogenic substitutions in Parkinson’s disease. Neurogenetics 2005, 6:171–177.PubMedCrossRefGoogle Scholar
  6. 6.
    Berg D, Schweitzer K, Leitner P, et al.: Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson’s disease. Brain 2005, 128:3000–3011.PubMedGoogle Scholar
  7. 7.
    Khan NL, Jain S, Lynch JM, et al.: Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson’s disease: clinical, pathological, olfactory and functional imaging and genetic data. Brain 2005, 128:2786–2796.PubMedCrossRefGoogle Scholar
  8. 8.
    Di Fonzo A, Tassorelli C, De Mari M, et al.: Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson’s disease. Eur J Hum Genet 2006, 14:322–331.PubMedCrossRefGoogle Scholar
  9. 9.
    Lesage S, Durr A, Tazir M, et al.: LRRK2 G2019S as a cause of Parkinson’s disease in North African Arabs. N Engl J Med 2006, 354:422–423.PubMedCrossRefGoogle Scholar
  10. 10.
    Ozelius LJ, Senthil G, Saunders-Pullman R, et al.: LRRK2 G2019S as a cause of Parkinson’s disease in Ashkenazi Jews. N Engl J Med 2006, 354:424–425.PubMedCrossRefGoogle Scholar
  11. 11.
    Bras JM, Guerreiro RJ, Ribeiro MH, et al.: G2019S dardarin substitution is a common cause of Parkinson’s disease in a Portuguese cohort. Mov Disord 2005, 20:1653–1655.PubMedCrossRefGoogle Scholar
  12. 12.
    Gaig C, Ezquerra M, Marti MJ, et al.: LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance. Arch Neurol 2006, 63:377–382.PubMedCrossRefGoogle Scholar
  13. 13.
    Goldwurm S, Di Fonzo A, Simons EJ, et al.: The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson’s disease and originates from a common ancestor. J Med Genet 2005, 42:e65.PubMedCrossRefGoogle Scholar
  14. 14.
    Funayama M, Hasegawa K, Kowa H, et al.: A new locus for Parkinson’s disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol 2002, 51:296–301.PubMedCrossRefGoogle Scholar
  15. 15.
    Wszolek ZK, Vieregge P, Uitti RJ, et al.: German-Canadian family (Family A) with parkinsonism, amyotrophy, and dementia—longitudinal observations. Parkinsonism Relat Disord 1997, 3:125–139.PubMedCrossRefGoogle Scholar
  16. 16.
    Wszolek ZK, Pfeiffer RF, Tsuboi Y, et al.: Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology 2004, 62:1619–1622.PubMedGoogle Scholar
  17. 17.
    Gilks WP, Abou-Sleiman PM, Gandhi S, et al.: A common LRRK2 mutation in idiopathic Parkinson’s disease. Lancet 2005, 365:415–416.PubMedGoogle Scholar
  18. 18.
    Ross OA, Toft M, Whittle AJ, et al.: Lrrk2 and Lewy body disease. Ann Neurol 2006, 59:388–393.PubMedCrossRefGoogle Scholar
  19. 19.
    Giasson BI, Covy JP, Bonini NM, et al.: Biochemical and pathological characterization of Lrrk2. Ann Neurol 2006, 59:315–322.PubMedCrossRefGoogle Scholar
  20. 20.
    Greggio E, Jain S, Kingsbury A, et al.: Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol Dis 2006, In press.Google Scholar

Copyright information

© Current Science Inc 2006

Authors and Affiliations

  1. 1.Department of Clinical GeneticsErasmus MCCA RotterdamThe Netherlands

Personalised recommendations